Cover Image
市場調查報告書

Maruho : 產品平台分析

Maruho Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226266
出版日期 內容資訊 英文 41 Pages
訂單完成後即時交付
價格
Back to Top
Maruho : 產品平台分析 Maruho Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 41 Pages
簡介

Maruho是正在進行各種皮膚疾病醫療用醫藥品之研究,開發,製造,銷售的醫藥品企業。

本報告提供Maruho的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

Maruho的基本資料

  • Maruho概要
  • 主要資訊
  • 企業資料

Maruho:R&D概要

  • 主要的治療範圍

Maruho:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Maruho:開發中產品概況

  • 最後階段的開發中產品
    • 登記前的產品/聯合治療模式
    • 第Ⅲ階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第Ⅱ階段的產品/聯合治療模式

Maruho:藥物簡介

  • benzoyl peroxide
  • betamethasone valerate + maxacalcitol
  • ozenoxacin
  • amenamevir
  • GK-664S
  • pefcalcitol
  • propranolol hydrochloride
  • lanoconazole
  • M-1170
  • M-7040
  • TA-7906

Maruho:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Maruho:最近的開發平台趨勢

Maruho:暫停中的計劃

Maruho:企業發表

Maruho:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07533CDB

Summary

Global Markets Direct's, 'Maruho Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Maruho Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Maruho Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Maruho Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Maruho Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Maruho Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Maruho Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Maruho Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Maruho Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Maruho Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Maruho Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Maruho Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Maruho Co., Ltd. Snapshot
    • Maruho Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Maruho Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Maruho Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Maruho Co., Ltd. - Pipeline Products Glance
    • Maruho Co., Ltd. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Maruho Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
  • Maruho Co., Ltd. - Drug Profiles
    • benzoyl peroxide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • betamethasone valerate + maxacalcitol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ozenoxacin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • amenamevir
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • GK-664S
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pefcalcitol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • propranolol hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • lanoconazole
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • M-1170
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • M-7040
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TA-7906
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Maruho Co., Ltd. - Pipeline Analysis
    • Maruho Co., Ltd. - Pipeline Products by Target
    • Maruho Co., Ltd. - Pipeline Products by Route of Administration
    • Maruho Co., Ltd. - Pipeline Products by Molecule Type
    • Maruho Co., Ltd. - Pipeline Products by Mechanism of Action
  • Maruho Co., Ltd. - Recent Pipeline Updates
  • Maruho Co., Ltd. - Dormant Projects
  • Maruho Co., Ltd. - Company Statement
  • Maruho Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Maruho Co., Ltd., Key Information
  • Maruho Co., Ltd., Key Facts
  • Maruho Co., Ltd. - Pipeline by Indication, 2015
  • Maruho Co., Ltd. - Pipeline by Stage of Development, 2015
  • Maruho Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Maruho Co., Ltd. - Combination Treatment Modalities in Pipeline, 2015
  • Maruho Co., Ltd. - Partnered Products in Pipeline, 2015
  • Maruho Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
  • Maruho Co., Ltd. - Pre-Registration, 2015
  • Maruho Co., Ltd. - Phase III, 2015
  • Maruho Co., Ltd. - Phase II, 2015
  • Maruho Co., Ltd. - Pipeline by Target, 2015
  • Maruho Co., Ltd. - Pipeline by Route of Administration, 2015
  • Maruho Co., Ltd. - Pipeline by Molecule Type, 2015
  • Maruho Co., Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Maruho Co., Ltd. - Recent Pipeline Updates, 2015
  • Maruho Co., Ltd. - Dormant Developmental Projects,2015
  • Maruho Co., Ltd., Other Locations
  • Maruho Co., Ltd., Subsidiaries

List of Figures

  • Maruho Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Maruho Co., Ltd. - Pipeline by Stage of Development, 2015
  • Maruho Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Maruho Co., Ltd. - Partnered Products in Pipeline, 2015
  • Maruho Co., Ltd. - Pipeline by Top 10 Target, 2015
  • Maruho Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Maruho Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Maruho Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top